None listed
Conditions
Brief summary
Many breast cancer survivors suffered from restrictions in quality of life and impaired physical and psychological function after finishing radiotherapy and chemotherapy, but current exercise interventions cannot provide all-round effect to treatment sequelae. GYROKINESIS 'Registered Trademark' is a new method containing flowing movement sequences that works the entire body, yet its clinical effects have not been investigated and have not been applied in the breast cancer population. The purpose of this study is to investigate the effectiveness of GYROKINESIS 'Registered Trademark' -based training on physical function and quality of life in breast cancer survivors.
Interventions
The intervention group will receive GYROKINESIS 'Registered Trademark' exercise training twice a week, lasting for 12 weeks in total. The exercise training will be delivered in a group format with a physiotherapist.
The duration of each training session will be 60-90 minutes long. Each class begins on a chair with a gentle warm up sequence to awaken the senses, and stimulate the nervous system. This is followed by a series of fluid spinal motions which increase range of motion, and prepare the
The intervention group will receive GYROKINESIS 'Registered Trademark' exercise training twice a week, lasting for 12 weeks in total. The exercise training will be delivered in a group format with a physiotherapist. The duration of each training session will be 60-90 minutes long. Each class begins on a chair with a gentle warm up sequence to awaken the senses, and stimulate the nervous system. This is followed by a series of fluid spinal motions which increase range of motion, and prepare the body to explore more complex movements with agility, and ease. Class continues on the floor with exercises that expand on the spinal motions, gradually adding more complex sequences, incorporating more movements of the hips, shoulders, hands and feet. The floor exercises are followed by a rhythmic standing sequence that incorporates balance, and cardiovascular exercises.
Sponsors
National Yang-Ming University
Study design
Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
(1) female, (2) diagnosed of stage 0-IV breast cancer, (3) within 5 years after finishing adjuvant therapy
Exclusion criteria
(1) active cancer, (2) under adjuvant therapy, (3) neurologic or rheumatic diseases, or (4) severe cardiovascular condition or other medical conditions
Outcome results
None listed